In conclusion, our findings illuminated the molecular association between glioma and COVID-19, emphasizing the PI3K-Akt signaling pathway and vitamin D-mediated immunomodulation as critical factors influencing disease progression and patient outcomes. Here, AKT1 is linked to COVID-19.